Population pharmacokinetics of ticarcillin in critically ill patients receiving extended daily diafiltration.

Int J Antimicrob Agents

University of Queensland Centre of Clinical Research, Faculty of Medicine, The University of Queensland, Brisbane, Queensland, Australia; Department of Intensive Care Medicine, Royal Brisbane and Women's Hospital, Brisbane, Queensland, Australia; Department of Pharmacy, Royal Brisbane and Women's Hospital, Brisbane, Queensland, Australia; Centre for Translational Anti-infective Pharmacodynamics, School of Pharmacy, The University of Queensland, Brisbane, Queensland, Australia; Division of Anaesthesiology Critical Care Emergency and Pain Medicine, Nîmes University Hospital, University of Montpellier, Nîmes France. Electronic address:

Published: September 2019

The aim of this study was to describe the population pharmacokinetics of ticarcillin during extended daily diafiltration (EDDf) in critically ill patients with acute kidney injury. Blood samples were collected from critically ill patients prescribed ticarcillin during one to two dosing intervals during which EDDf was performed. Plasma samples were measured using a validated ultra high performance liquid chromatography-tandem mass spectrometry (UHPLC-MS/MS) method. Concentration-time data were analysed using a population pharmacokinetics approach with Pmetrics®. A total of 53 blood samples were collected from six critically ill patients (three male). The mean ± standard deviation patient age, weight and body mass index (BMI) was 43 ± 22 years, 88 ± 14 kg and 31 ± 5 kg/m, respectively. A two-compartment linear model adequately described the data. Median population pharmacokinetic parameter estimates were as follows: clearance in the presence of EDDf (CL), 6.41 L/h; clearance of EDDf (CL), 4.97 L/h; volume of distribution of the central compartment (V), 56.46 L; intercompartmental clearance from the central to peripheral compartment (k), 13.54 L/h; and intercompartmental clearance from the peripheral to central compartment (k), 21.93 L/h. This is the first population pharmacokinetic model of ticarcillin in patients receiving EDDf. Large pharmacokinetic variability was found, supporting further investigation of the pharmacokinetics of less-studied β-lactam antibiotics in prolonged intermittent renal replacement therapy.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijantimicag.2019.06.027DOI Listing

Publication Analysis

Top Keywords

critically ill
16
ill patients
16
population pharmacokinetics
12
pharmacokinetics ticarcillin
8
patients receiving
8
extended daily
8
daily diafiltration
8
blood samples
8
samples collected
8
collected critically
8

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!